Published in J Pharm Pharmacol on June 01, 1981
Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology (1990) 1.65
Pontine lesions in idiopathic narcolepsy. Neurology (1996) 1.48
The hypersensitivity of adipose tissue to norepinephrine and other lipolytic agents during blockade of free fatty acids (FFA) mobilization. Biochem Pharmacol (1969) 1.40
GJA12 mutations in children with recessive hypomyelinating leukoencephalopathy. Neurology (2006) 1.39
Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology (1992) 1.28
Mechanism of potassium relaxation of arterial muscle. Blood Vessels (1977) 1.25
Aluminum effect on slow axonal transport: a novel impairment of neurofilament transport. J Neurosci (1984) 1.21
Natural history and management of brainstem gliomas in adults. A retrospective Italian study. J Neurol (2008) 1.18
Potentiation of noradrenaline isomers by cocaine and desipramine in the isolated vas deferens of the rat. J Pharm Pharmacol (1967) 1.09
Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells. J Virol (1999) 1.04
Norepinephrine release in isolated arteries induced by K-free solution. Am J Physiol (1977) 1.03
Transcription pattern of human herpesvirus 8 open reading frame K3 in primary effusion lymphoma and Kaposi's sarcoma. J Virol (2001) 1.02
Diffusion tensor imaging shows different topographic involvement of the thalamus in progressive supranuclear palsy and corticobasal degeneration. AJNR Am J Neuroradiol (2009) 1.02
Description and preliminary evaluation of a new ultrasonic atomizer for spray-congealing processes. Int J Pharm (1999) 1.01
Absolute quantitation of short TE brain 1H-MR spectra and spectroscopic imaging data. J Comput Assist Tomogr (1993) 0.97
Phosphorylation of neurofilaments is altered in aluminium intoxication. Acta Neuropathol (1986) 0.94
Our experience with nifedipine and prednisolone as expulsive therapy for ureteral stones. Urol Int (2004) 0.93
Epidemiological problems with TCDD (a critical view). Drug Metab Rev (1982) 0.92
Anorexia and cancer in animals and man. Cancer Treat Rev (1980) 0.92
D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis. Thromb Haemost (2011) 0.91
Steroid receptors in epithelial ovarian carcinoma: relation to clinical parameters and survival. Cancer Res (1988) 0.91
Piracetam: physiological disposition and mechanism of action. Adv Neurol (1986) 0.90
Hemophagocytic lymphohistiocytosis with neurological presentation: MRI findings and a nearly miss diagnosis. Neurol Sci (2011) 0.90
Bio-image warehouse system: concept and implementation of a diagnosis-based data warehouse for advanced imaging modalities in neuroradiology. J Digit Imaging (2007) 0.90
Detection of hepatitis A antibodies by ELISA using saliva as clinical samples. Rev Inst Med Trop Sao Paulo (2000) 0.90
Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence. J Thromb Haemost (2005) 0.90
Anorectic activity of fluoxetine and norfluoxetine in rats: relationship between brain concentrations and in-vitro potencies on monoaminergic mechanisms. J Pharm Pharmacol (1992) 0.89
Anoxia-inducible endonuclease activity as a potential basis of the genomic instability of cancer cells. Cancer Res (1992) 0.88
Stimulatory effect of ethanol on glycerol release from rat adipose tissue in vitro. Life Sci (1965) 0.88
Cerebral white matter involvement in children with mitochondrial encephalopathies. Neuropediatrics (2002) 0.87
Effects of amphetamine and fenfluramine on the net release of triglycerides of very low density lipoproteins by slices of rat liver. Biochem Pharmacol (1972) 0.87
Effect of desipramine on directly or indirectly elicited catecholamine pressor responses in rats. J Pharm Pharmacol (1966) 0.87
Brainstem encephalitis resulting from Epstein-Barr virus mimicking an infiltrating tumor in a child. Pediatr Neurol (2000) 0.86
(R,S)-3,4-dichlorobenzoylalanine (FCE 28833A) causes a large and persistent increase in brain kynurenic acid levels in rats. Eur J Pharmacol (1996) 0.86
Anorectic activity of fluoxetine and norfluoxetine in mice, rats and guinea-pigs. J Pharm Pharmacol (1992) 0.86
Genetic and metabolic effects of gluconasturtiin, a glucosinolate derived from cruciferae. Mutat Res (2004) 0.86
Stone composition: where do we stand? Urol Int (2007) 0.85
Comparative studies on the anorectic activity of d-fenfluramine in mice, rats, and guinea pigs. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.85
ESWL: Comparing two analgesic techniques. Our experience. Urol Int (2004) 0.85
Interlaboratory reproducibility in reporting inadequate cervical smears--a multicentre multinational study. Cytopathology (1996) 0.84
Lowering of blood ketone bodies induced by drugs preventing free fatty acid mobilization. Experientia (1966) 0.84
MR imaging and proton MR spectroscopy in adult Krabbe disease. AJNR Am J Neuroradiol (2000) 0.84
Cerebral white matter in the centrum semiovale exhibits a larger N-acetyl signal than does gray matter in long echo time 1H-magnetic resonance spectroscopic imaging. Magn Reson Med (1995) 0.83
Concentrations of desipramine in the vas deferens and potentiation of noradrenaline response. Br J Pharmacol (1971) 0.83
Consciousness disturbances in megalencephalic leukoencephalopathy with subcortical cysts. Neuropediatrics (2003) 0.83
Effects of ultrasound-assisted compaction on Ketoprofen/Eudragit S100 mixtures. Eur J Pharm Sci (1999) 0.83
Studies on the hypertensive response elicited by reserpine or tetrabenazine in rats treated with amphetamine-like drugs. Eur J Pharmacol (1968) 0.83
A family with Alzheimer disease and strokes associated with A713T mutation of the APP gene. Neurology (2004) 0.83
The action of desipramine on noradrenaline depletion by reserpine in the vas deferens of the rat in vivo. J Pharm Pharmacol (1970) 0.83
Role of surfactant in chronic obstructive pulmonary disease: therapeutic implications. Respiration (1992) 0.83
Multifocal angiomyolipoma in a patient with tuberous sclerosis. Clin Imaging (1996) 0.83
Role of cell cholesterol in modulating antineoplastic ether lipid uptake, membrane effects and cytotoxicity. Int J Cancer (1990) 0.82
The effects of aging on MAO activity and amino acid levels in rat brain. J Neural Transm Suppl (1990) 0.81
Protective effects of vitamins and selenium compounds in yeast. Mutat Res (2001) 0.81
Progress report on the anorexia induced by drugs believed to mimic some of the effects of serotonin on the central nervous system. Am J Clin Nutr (1992) 0.81
A new rapid bedside assay for D-dimer measurement (Simplify D-dimer) in the diagnostic work-up for deep vein thrombosis. J Thromb Haemost (2003) 0.81
Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study. Aliment Pharmacol Ther (2007) 0.81
The Wells rule and D-dimer for the diagnosis of isolated distal deep vein thrombosis. J Thromb Haemost (2012) 0.81
Relationships between chronotropic effect, 1-3H-noradrenaline uptake and tissue concentrations of desipramine, protripyline and doxepin in rat isolated atria. Arch Int Pharmacodyn Ther (1976) 0.80
Plasma concentrations and cardiotoxic effects of desipramine and protriptyline in the rat. Br J Pharmacol (1977) 0.80
Accelerated recovery of post-dialysis plasma carnitine fall by oral carnitine. Biomedicine (1978) 0.80
Diazepam binding inhibitor (DBI) increases after acute stress in rat. Neuropharmacology (1991) 0.80
Valproate, carnitine metabolism, and biochemical indicators of liver function. Collaborative Group for the Study of Epilepsy. Epilepsia (1990) 0.80
Cardiac output distribution measured with radioactive microspheres in the mouse. Pharmacol Res Commun (1979) 0.80
Brain concentrations of kynurenic acid after a systemic neuroprotective dose in the gerbil model of global ischemia. Prog Neuropsychopharmacol Biol Psychiatry (1999) 0.80
[Generalised triglyceride lipidosis (triglyceridosis). 1st anatomo-clinical report]. Rev Neurol (Paris) (1975) 0.80
Effect of ageing on tissue levels of amino acids involved in the nitric oxide pathway in rat brain. J Neural Transm Gen Sect (1993) 0.79
Uptake of desipramine by the rat vas deferens. Br J Pharmacol (1972) 0.79
Some aspects of the effect of nicotine on plasma FFA and tissue triglycerides. Pharmacology (1972) 0.79
The influence of desipramine on the sensitivity and accumulation of noradrenaline in the isolated tail artery of the rat. Eur J Pharmacol (1970) 0.79
DNA ploidy and TLI in association with other prognostic parameters in breast cancer. Anticancer Res (1999) 0.79
Magnetic resonance imaging in Alzheimer's disease: from diagnosis to monitoring treatment effect. Curr Alzheimer Res (2012) 0.78
A novel pharmacological approach for paraquat poisoning in rat and A549 cell line using ambroxol, a lung surfactant synthesis inducer. Food Chem Toxicol (1992) 0.78
Further observations on the attachment of carbohydrate to lipoproteins by rat liver Golgi membranes. Proc Soc Exp Biol Med (1973) 0.78
Correlation between desipramine levels and (-)-noradrenaline uptake and chronotropic effect in isolated atria of rats. Br J Pharmacol (1973) 0.78
Different responses of white and brown adipose tissue to drugs affecting lipolysis. Biochem Pharmacol (1968) 0.78
Elevating tensor rank increases anisotropy in brain areas associated with intra-voxel orientational heterogeneity (IVOH): a generalised DTI (GDTI) study. NMR Biomed (2008) 0.78
Role of calcium in chloride secretion mediated by cAMP pathway activation in rabbit distal colon mucosa. Am J Physiol (1993) 0.78
Pharmacological studies on isolated and perfused rat renal arteries. Eur J Pharmacol (1967) 0.77
Effect of hydrocortisone on the macrophage content, growth and metastasis of transplanted murine tumors. Int J Cancer (1984) 0.77
Relationship between lipolysis and storage of corticosterone in adipose tissue. Biochem Pharmacol (1972) 0.77
Amiodarone induced phospholipidosis. Biochemical, morphological and functional changes in the lungs of rats chronically treated with amiodarone. Biochem Pharmacol (1987) 0.77
Sexual behavior and hemispheric laterality of the focus in patients with temporal lobe epilepsy. Biol Psychiatry (1997) 0.77
Effect of fenfluramine on the intestinal absorption of triglycerides. Eur J Pharmacol (1973) 0.77
Role of 5-HT receptors in the effect of d-fenfluramine on gastric emptying and feeding behaviour as examined in the runway test. Eur J Pharmacol (1991) 0.77
Progress in assessing the role of serotonin in the control of food intake. Clin Neuropharmacol (1988) 0.77
Expression of the hepatitis B virus surface antigen in mammalian cells using an Epstein-barr-virus-derived vector. Appl Microbiol Biotechnol (1996) 0.77
Fate of 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET18-OME) in malignant cells, normal cells, and isolated and perfused rat liver. Drug Metab Dispos (1995) 0.77
G20210A prothrombin mutation and critical limb ischaemia in patients with peripheral arterial disease. Eur J Vasc Endovasc Surg (2009) 0.77
Hepatitis E virus immunoglobulin G antibodies in different populations in Campinas, Brazil. Clin Diagn Lab Immunol (2000) 0.77
Accumulation and metabolism of uneven fatty acids present in single cell protein. Toxicol Lett (1980) 0.77
Caffeine disposition and effects in young and one-year old rats. J Pharm Pharmacol (1980) 0.76
Modulation of extracellular kynurenic acid content by excitatory amino acids in primary cultures of rat astrocytes. Adv Exp Med Biol (1996) 0.76
Adriamycin causes hyperlipemia as a consequence of nephrotoxicity. Toxicol Lett (1983) 0.76
Plasma and platelet lipid composition and platelet aggregation by arachidonic acid in women on the pill. Thromb Haemost (1981) 0.76